Saturday 17 October 2026
Export ICLR’s income statement to Excel — free account
ICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024. In the quarter to June 2026, revenue grew 1.20%, EPS fell 59.3%, free cash flow grew 109.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.
170.18
4.95
−2.83%
Follow ICLR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
15.53 | 22.06 | 21.68 | 25.14 | 31.45 | 102.89 | 31.27 | 37.64 | 23.39 | 70.64 |
Piotroski F-Score |
7 | 6 | 7 | 5 | 5 | 3 | 7 | 8 | 7 | 6 |
Altman Z-Score |
5.06 | 5.93 | 6.72 | 6.65 | 5.95 | 1.87 | 1.88 | 2.71 | 2.41 | 2.01 |
P/S ratio |
2.48 | 3.52 | 2.69 | 3.31 | 3.68 | 3.79 | 2.04 | 2.84 | 2.11 | 1.73 |
P/FCF ratio |
19.06 | 18.31 | 31.75 | 25.63 | 19.55 | 28.26 | 37.48 | 22.60 | 15.46 | 16.58 |
Altman Z″-Score (non-manufacturers) |
4.99 | 5.13 | 5.72 | 4.75 | 5.06 | 1.50 | 1.89 | 2.32 | 2.57 | 2.10 |
Beneish M-Score |
(2.42) | (2.69) | (1.97) | (2.32) | (2.53) | (1.30) | (2.24) | (2.56) | (2.77) | (2.62) |
P/Operating CF |
31.71 | 58.52 | 114.89 | 69.00 | 52.74 | 71.71 | (265.60) | 52.38 | 51.13 | 61.03 |
P/B ratio |
4.37 | 5.20 | 5.16 | 5.60 | 5.57 | 2.58 | 1.86 | 2.49 | 1.83 | 1.55 |
Price to Tangible BV |
15.15 | 17.69 | 12.86 | 13.13 | 12.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.74 | 3.72 | 2.79 | 3.26 | 3.52 | 4.65 | 2.60 | 3.26 | 2.46 | 2.07 |
EV/EBITDA |
12.30 | 16.35 | 16.47 | 17.39 | 21.50 | 36.72 | 14.76 | 17.15 | 13.27 | 20.64 |
EV/Operating CF |
17.61 | 17.06 | 26.94 | 22.14 | 17.32 | 30.71 | 35.77 | 22.78 | 15.69 | 16.45 |
EV/FCF |
21.08 | 19.31 | 32.86 | 25.24 | 18.66 | 34.63 | 47.84 | 25.92 | 18.04 | 19.77 |
Quick Ratio |
1.48 | 1.41 | 1.52 | 1.03 | 1.44 | 0.89 | 0.79 | 0.82 | 0.79 | 0.72 |
Current Ratio |
1.94 | 1.95 | 2.18 | 1.44 | 1.87 | 1.19 | 1.20 | 1.21 | 1.24 | 1.10 |
Net Debt/EBITDA |
0.24 | (0.03) | (0.24) | (0.27) | (1.03) | 6.75 | 3.20 | 2.20 | 1.90 | 3.34 |
Debt/Assets |
19.09% | 16.25% | 14.84% | 14.67% | 10.84% | 31.27% | 27.08% | 22.22% | 20.60% | 20.91% |
Debt/Equity |
0.37 | 0.29 | 0.26 | 0.26 | 0.20 | 0.67 | 0.55 | 0.41 | 0.36 | 0.37 |
Asset Turnover |
0.94 | 0.89 | 1.15 | 1.07 | 0.88 | 0.53 | 0.45 | 0.48 | 0.49 | 0.50 |
Operating CF/Net income |
0.99 | 1.36 | 0.83 | 1.10 | 1.71 | 5.41 | 1.11 | 1.90 | 1.74 | 4.52 |
Capex/Depreciation |
(0.72) | (0.73) | (0.73) | (0.55) | (0.62) | (0.30) | (0.25) | (0.24) | (0.34) | (0.45) |
Interest Coverage |
23.97 | 26.79 | 27.65 | 32.65 | 30.07 | 2.08 | 3.46 | 2.84 | 4.35 | 2.24 |
| 30.70% | 26.35% | 25.35% | 24.83% | 18.95% | 3.09% | 6.10% | 6.90% | 7.91% | 2.46% | |
| 14.80% | 14.17% | 14.34% | 14.22% | 10.48% | 1.47% | 2.92% | 3.58% | 4.40% | 1.39% | |
ROIC |
18.86% | 17.93% | 18.70% | 17.89% | 17.72% | 1.86% | 3.86% | 4.73% | 5.23% | 2.32% |
Return on Tangible Assets |
42.80% | 40.33% | 36.74% | 56.77% | 28.81% | 19.18% | 56.85% | 64.66% | 72.28% | 32.71% |
Average Days of Receivables |
102.83 | 90.85 | 66.75 | 76.85 | 101.62 | 96.55 | 86.94 | 87.53 | 69.34 | 73.10 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
19.55% | 18.41% | 12.55% | 12.00% | 12.24% | 10.68% | 10.06% | 9.46% | 8.89% | 9.45% |
Intangible Assets out of Total Assets |
0.37 | 0.39 | 0.34 | 0.33 | 0.29 | 0.79 | 0.77 | 0.76 | 0.76 | 0.74 |
Share Based Compensation of Revenue |
2.42% | 1.74% | 1.22% | 0.96% | 0.94% | 2.44% | 0.91% | 0.69% | 0.56% | 1.24% |
Graham Net Nets |
0.02 | 0.02 | 0.05 | 0.04 | 0.05 | (0.31) | (0.35) | (0.19) | (0.23) | (0.25) |
Graham Number |
43.03 | 50.69 | 57.93 | 68.87 | 69.88 | 90.23 | 120.48 | 137.45 | 151.96 | 82.48 |
Earnings Yield |
6.44% | 4.53% | 4.61% | 3.98% | 3.18% | 0.97% | 3.20% | 2.66% | 4.28% | 1.42% |
Free Cash Flow Yield |
5.25% | 5.46% | 3.15% | 3.90% | 5.11% | 3.54% | 2.67% | 4.43% | 6.47% | 6.03% |
Revenue per Share |
30.16 | 32.49 | 47.96 | 52.10 | 52.92 | 81.67 | 94.95 | 98.90 | 99.28 | 105.21 |
Operating CF per Share |
4.69 | 7.08 | 4.96 | 7.66 | 10.75 | 12.36 | 6.91 | 14.14 | 15.60 | 13.21 |
Capex per Share |
(0.77) | (0.83) | (0.89) | (0.94) | (0.77) | (1.40) | (1.74) | (1.71) | (2.04) | (2.22) |
Free Cash Flow per Share |
3.92 | 6.25 | 4.07 | 6.72 | 9.97 | 10.96 | 5.17 | 12.43 | 13.56 | 10.99 |
Cash per Share |
4.72 | 6.66 | 8.42 | 10.58 | 15.93 | 11.23 | 3.56 | 4.63 | 6.53 | 8.25 |
Shareholders Equity per Share |
17.11 | 22.00 | 25.02 | 30.78 | 35.00 | 120.20 | 104.23 | 112.55 | 114.46 | 117.23 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
17.11 | 22.00 | 25.02 | 30.78 | 35.00 | 120.20 | 104.23 | 112.55 | 114.46 | 117.23 |
Free Cash Flow |
216.60 | 338.37 | 220.24 | 361.90 | 527.15 | 735.39 | 421.16 | 1,020.34 | 1,118.59 | 861.99 |
Working Capital |
463.55 | 534.96 | 719.56 | 493.73 | 979.04 | 462.26 | 538.47 | 585.86 | 639.68 | 305.50 |
Capital Expenditures |
(42.60) | (44.72) | (48.40) | (50.64) | (40.88) | (93.75) | (142.16) | (140.69) | (168.06) | (174.21) |
Net Current Asset Value |
77.29 | 145.40 | 330.21 | 375.03 | 517.61 | (6,379.06) | (5,458.25) | (4,337.65) | (3,918.30) | (3,574.72) |
EV/EBIT |
14.65 | 19.32 | 19.38 | 21.07 | 25.13 | 67.28 | 25.34 | 27.66 | 19.55 | 38.49 |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Price to Operating Income |
13.24 | 18.32 | 18.73 | 21.40 | 26.33 | 54.91 | 19.85 | 24.11 | 16.75 | 32.27 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.40 | 0.38 | 0.42 | 0.56 | 0.38 | 0.94 | 1.63 | 1.62 | 1.28 | 0.97 |
Cash ROIC |
13.94% | 17.81% | 10.20% | 13.64% | 17.20% | 5.16% | 3.13% | 7.62% | 8.34% | 6.51% |
Accounts Receivable Turnover |
3.57 | 3.88 | 5.69 | 5.27 | 4.09 | 4.92 | 4.70 | 4.28 | 4.68 | 5.14 |
Accounts Payable Turnover |
122.33 | 75.30 | 114.07 | 105.74 | 52.68 | 56.00 | 64.28 | 53.76 | 38.20 | 33.28 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
3.30 | 6.61 | 2.67 | 4.45 | 9.42 | 8.34 | 5.36 | 8.40 | 10.85 | 11.54 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
466.29 | 453.60 | 456.19 | 532.73 | 684.77 | 1,114.31 | 1,646.83 | 1,895.60 | 1,751.57 | 1,604.12 |
Average Payables |
7.86 | 13.64 | 15.94 | 18.67 | 37.58 | 70.94 | 85.98 | 106.39 | 152.30 | 182.57 |
Average Assets |
1,771.53 | 1,986.23 | 2,250.44 | 2,630.88 | 3,171.56 | 10,411.35 | 17,286.19 | 17,087.57 | 16,812.34 | 16,452.30 |
Average Common Equity |
854.13 | 1,068.09 | 1,272.64 | 1,505.92 | 1,753.90 | 4,958.53 | 8,282.40 | 8,869.35 | 9,341.05 | 9,317.37 |
Columns are period end dates